Light chain (AL) Amyloidosis/Primary

Attralus is developing novel pan-amyloid removal (PAR) therapeutics that directly bind to and remove toxic amyloid, opening the potential to treat and reverse…

BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.

March being Amyloidosis Awareness Month, it's a good time to tell the story of Steven Szymanski, who, until finally diagnosed with it, was roughly as familiar with…

The most widely used system is the European modification of the original 3-stage Mayo 2004 system which uses Troponin T or I and NT-pro-BNP to divide patients into…

The FDA has approved daratumumab and hyaluronidase-fihj (Darzalex Faspro), a subcutaneous formulation of daratumumab, for use in combination with bortezomib,…

Mayo Clinic School of Continuous Professional Development May 23, 2021 Hilton - Mayo Clinic Area, Rochester, MN, USA Course Directors: Shaji Kumar, MDexternal…

AL amyloidosis patients often have queries about diet and nutrition - about what types of foods are best to eat or avoid, or if there are any special diets they…